1.1.1 - Regulatory Scope and Product Qualification
0% read
Regulatory Framework and Transitions
Regulatory Scope and Product Qualification
Before a manufacturer can classify a product, select a conformity assessment pathway, or assemble technical documentation, it must establish which regulatory framework applies. This lesson develops a repeatable, evidence-based process for distinguishing medical devices, in vitro diagnostic medical devices, accessories, medicinal products, borderline products, and products without an intended medical purpose.
What you will learn
Apply MDR Articles 1 and 2 and IVDR Articles 1 and 2 to determine regulatory applicability from intended purpose and product characteristics.
Distinguish ordinary medical devices from IVDs, accessories, general laboratory products, medicinal products, and medical device software.
Screen nonmedical-purpose products against MDR Annex XVI and applicable common specifications.
Prepare a concise, evidence-supported regulatory applicability memorandum that identifies unresolved questions and appropriate next actions.
Estimated learning time
20-25 minutes.
Blueprint mapping
EU MDR and IVDR Regulatory Framework, Responsibilities, and Transition Planning - Determine MDR and IVDR Applicability (2% of the overall assessment); related foundational classification and pathway objectives in Domain 2. Domain 1 overall weighting: 9%.
Prerequisites
None.
Key output
A defensible decision between MDR, IVDR, another regulatory framework, a specific exclusion or special pathway, or further documented regulatory assessment.
WHY
Why it matters
The wrong framework produces the wrong compliance program. MDR and IVDR differ in classification, evidence requirements, conformity assessment, and certain post-market obligations.
Qualification precedes classification. A product cannot be assigned an MDR or IVDR risk class merely because its technology appears similar to that of an established device.
Commercial terminology is not determinative. Software, laboratory kits, accessories, and aesthetic products must be evaluated using their actual documented intended purposes and applicable regulatory definitions.
Regulatory obligations begin with scope. MDR became generally applicable on 26 May 2021 and IVDR on 26 May 2022. As of 1 November 2026, transitional arrangements do not eliminate the need for a defensible scope determination.
Key rule: Establish intended purpose, apply the statutory definition, consider the principal intended action and applicable exclusions, and only then determine classification and conformity assessment requirements. A manufacturer's preferred commercial category does not replace the regulatory analysis.
KEY TERMS
Key Terms & Must-Know Facts
Medical device
An instrument, apparatus, appliance, software, implant, reagent, material, or other article intended by its manufacturer for specified medical purposes and meeting the MDR definition, including the relevant principal-action limitation.
In vitro diagnostic medical device (IVD)
A reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software, or system intended by its manufacturer to examine specimens derived from the human body in vitro for information within the IVDR definition.
Intended purpose
The use intended by the manufacturer as reflected in supplied information and relevant promotional or sales statements and, where applicable, evaluation documentation.
Principal intended action
The main intended way a product achieves its purpose; distinguishing a device from a medicinal product may require assessment of pharmacological, immunological, or metabolic action.
Accessory
An article that is not itself the relevant device but is specifically intended by its manufacturer to enable or directly assist the medical functionality of particular devices, within the applicable MDR or IVDR definition.
Medical device software
Software that independently meets a relevant medical device or IVD definition through its intended purpose; software that merely stores or communicates data does not automatically qualify.
Research-use-only product
A product presented for research rather than qualifying clinical diagnostic use; the designation must be consistent with documented claims and actual intended use.
Borderline product
A product whose qualification requires careful assessment because medical device, IVD, medicinal product, cosmetic, general laboratory, or other regulatory concepts may overlap.
Combination product
A product or configuration incorporating elements governed by more than one regulatory concept, requiring assessment of the applicable legal provisions and the relationship between the components.
MDR Annex XVI product
A product group identified by the MDR despite lacking an intended medical purpose, subject to applicable conditions and common specifications.
Common specifications
Regulatory specifications that may establish applicable requirements for specified products or product groups, including those addressed under the Annex XVI framework.
Health-institution exemption
A conditional statutory arrangement for qualifying products manufactured and used within health institutions; it does not create a universal exemption for hospitals or laboratories.
Regulatory applicability memorandum
A controlled record describing the product, intended-purpose evidence, relevant definitions, scope conclusion, exclusions, uncertainties, and supporting rationale.
Table 1. Foundational regulatory reference points
Reference
Primary relevance
Qualification question
MDR Articles 1-2
Scope and definitions
Does the product qualify as a medical device, accessory, or other product subject to MDR?
IVDR Articles 1-2
Scope and definitions
Is the product intended for qualifying in vitro examination of human-derived specimens?
MDR Annex XVI
Specified nonmedical-purpose groups
Is the product covered despite having no intended medical purpose?
Implementing Regulation 2022/2346, as amended
Annex XVI common specifications
Which applicable common specifications and transitional provisions must be checked?
MDR and IVDR Article 5
Placing on the market, putting into service, and relevant conditions
Are specific statutory conditions or health-institution provisions relevant?
MDR and IVDR Annex VIII
Classification after qualification
Which classification rules apply once the regulatory status is established?
Must-know facts:
The MDR and IVDR are distinct EU regulations with general application dates of 26 May 2021 and 26 May 2022 respectively.
Manufacturer-defined intended purpose is a primary qualification input, but potentially conflicting promotional statements or product evidence must be investigated.
A diagnostic claim does not automatically mean IVDR: the specimen-examination element matters.
Software can qualify under MDR or IVDR without being embedded in physical hardware.
Accessories require their own statutory qualification assessment.
A research label does not neutralize clinical diagnostic claims or uses attributable to the manufacturer.
Annex XVI can bring specified nonmedical-purpose products within MDR requirements.
Health-institution and legacy transition questions require separate eligibility assessments after the initial scope review.
CORE
Core content
1.1.1.1 1. Establish intended purpose before selecting a regulation
A Explanation and decision conflict
WHY THIS IS TESTED: The most frequent foundational error is choosing a legal category from product appearance or commercial naming before identifying what the manufacturer actually intends the product to accomplish.
Compare two visually identical imaging applications. One is presented only for administrative image transfer and archival. Another analyzes an image and provides information for diagnosis. Their software architecture may overlap, but the documented intended functions raise different regulatory questions. Conversely, deleting medical language from a product name does not automatically eliminate other manufacturer statements that communicate a medical intended purpose.
Collect labeling, instructions for use, website claims, sales materials, intended-user descriptions, functional specifications, and relevant evaluation documents. Identify the target patient or specimen, the information or effect produced, the user, and the clinical decision or activity supported. Where sources conflict, do not select the least regulated interpretation without investigation.
Use the sequence in Fig 1 to prevent premature classification.
1. Gather claims
Collect controlled intended-purpose statements and relevant external representations.
2. Characterize function
Identify inputs, outputs, users, specimen involvement, and intended medical effect.
3. Compare definitions
Assess MDR and IVDR definitions without yet assigning a risk class.
4. Screen exclusions
Review plausible nondevice, medicinal, laboratory, and special-product pathways.
5. Document conclusion
Record decisive evidence, missing information, and follow-up actions.
Fig 1. Intended-purpose-first qualification pathway Exam takeaway: Documented intended purpose is assessed before MDR or IVDR classification.
flowchart TD
A[Collect intended-purpose evidence] --> B[Define intended function and users]
B --> C{Qualifying medical or IVD purpose?}
C -->|Potentially yes| D[Apply relevant statutory definitions]
C -->|Not established| E[Check Annex XVI and other frameworks]
D --> F[Assess exclusions and principal action]
E --> G[Document outcome or uncertainty]
F --> G
Intended-purpose evidence dossier Exam takeaway: A qualification conclusion must be traceable to consistent manufacturer claims and functional evidence.
{"prompt":"Original square professional regulatory education vector illustration on a white background with generous margins. Show a central product qualification folder connected to five clearly labeled evidence cards: Labeling, Instructions for Use, Website Claims, Functional Specification, and Intended User. Cool blue and gray palette, thin precise outlines, one restrained teal accent, crisp readable labels, no photographs, gradients, textures, or decorative backgrounds.","caption":"Sources of intended-purpose evidence","size":"1024x1024"}
B Worked example: administrative versus diagnostic software
A 68-year-old patient with hypertension and chronic kidney disease undergoes radiographic imaging. The manufacturer markets two software modules. Module A archives images and allows staff to retrieve them. Module B evaluates image findings and outputs a suspected abnormality to assist clinical diagnosis. A laboratory glucose result is also displayed in the hospital interface, but neither module processes it. Marketing describes both modules as advanced workflow tools.
Extract facts: Module A provides administrative storage; Module B produces diagnostic information. The patient's comorbidities and glucose value do not determine product scope.
Apply the rule: Examine each manufacturer's intended function under the MDR definition and software qualification principles.
Eliminate distractors: The shared platform and workflow terminology do not override the diagnostic output of Module B.
Verify: Document Module B as a potential MDR medical device requiring full qualification and subsequent classification. Confirm Module A's complete claims before concluding it is outside MDR.
C Exam trap
Tempting wrong conclusion: All software deployed in a hospital is medical device software because it is used during patient care. Why tempting: The clinical setting creates an apparent medical association. Eliminating clue: The manufacturer's intended output is limited to administrative storage and retrieval rather than a qualifying medical purpose.
D Checkpoint MCQ
Question: What is the best first step when a software product's technical description and promotional claims appear inconsistent?
A. Assign an MDR classification using the software's most complex function.
B. Consolidate the intended-purpose evidence and resolve the conflicting claims.
C. Adopt the least regulated interpretation stated in the instructions for use.
D. Select IVDR whenever patient information is processed digitally.
Correct answer: B. A is tempting because classification appears decisive, but scope comes first. B is correct because conflicting manufacturer evidence must be reconciled before qualification. C is tempting because instructions for use are important, but other relevant manufacturer claims cannot be ignored. D is tempting because digital patient data may be diagnostic, but IVDR requires a qualifying in vitro specimen-related intended purpose.
If you missed this: Review Establish intended purpose before selecting a regulation - focus on resolving manufacturer claims before assigning product status.
1.1.1.2 2. Distinguish MDR devices, IVDR devices, and adjacent categories
A Explanation and decision conflict
WHY THIS IS TESTED: A product that provides medical information may still belong under different regulatory frameworks depending on the intended purpose, specimen relationship, and principal intended action.
MDR medical devices include qualifying products intended for diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of disease or other purposes specified in the definition. A key distinction from medicinal products is that the principal intended action is not achieved by pharmacological, immunological, or metabolic means, although such means may assist the action.
IVDR is concerned with qualifying products intended for the in vitro examination of specimens derived from the human body, including relevant blood and tissue donations, to provide specified information. Relevant information may concern a pathological or physiological process or state, a congenital impairment, predisposition to a medical condition or disease, safety and compatibility with potential recipients, treatment response, or therapeutic monitoring. The definition also addresses specimen receptacles.
A blood-based assay for an intended clinical diagnostic claim generally triggers IVDR analysis. A physiological monitor that measures signals directly from a patient generally triggers MDR analysis. A general laboratory instrument does not automatically become an IVD simply because a hospital laboratory purchases it.
1. Identify the claimed information or action
Separate clinical purpose from equipment location.
2. Check human-derived specimens
Determine whether the product is intended for examination in vitro.
3. Evaluate the relevant definition
Apply IVDR or MDR qualification criteria.
4. Test adjacent categories
Assess general laboratory use, accessories, medicinal action, and combined functions.
5. Record the product-specific conclusion
Retain uncertainty when decisive intended-purpose facts are missing.
See Fig 2 for the primary separation between MDR and IVDR.
Fig 2. MDR and IVDR qualification decision tree Exam takeaway: An in vitro examination of a human-derived specimen for qualifying information points toward IVDR rather than ordinary MDR qualification.
flowchart TD
A[Identify manufacturer intended purpose] --> B{In vitro examination of human-derived specimen?}
B -->|Yes| C{Qualifying IVDR information or purpose?}
C -->|Yes| D[Assess IVDR definition and exclusions]
C -->|No or unclear| E[Investigate laboratory or other status]
B -->|No| F{Qualifying MDR medical purpose?}
F -->|Yes| G[Assess MDR definition and exclusions]
F -->|No or unclear| H[Assess other frameworks and Annex XVI]
D --> I[Document product qualification]
E --> I
G --> I
H --> I
Table 2. MDR, IVDR, and neighboring product categories
Product characteristic
Likely qualification direction
Decisive assessment
Measures physiological signals directly from a patient to monitor a condition
MDR
Medical purpose and device definition
Analyzes a human blood specimen to provide clinical diagnostic information
IVDR
In vitro specimen examination and IVDR information purpose
General laboratory equipment without specific qualifying IVD claims
Potentially outside IVDR
Manufacturer's actual intended application
Software interpreting patient images for diagnosis
Potential MDR
Independent medical purpose of software
Software interpreting IVD specimen data for diagnostic information
Potential IVDR
Intended IVD function and manufacturer claims
Product with principal pharmacological action
Assess medicinal product framework
Principal intended action and applicable combination rules
Accessory definition and specified device relationship
Direct patient measurement versus specimen examination Exam takeaway: The location and nature of the information-generating examination help distinguish MDR and IVDR pathways.
{"prompt":"Square medical regulatory training comparison illustration. Left panel labeled MDR: an adult patient wearing a physiological monitor connected to a measurement display. Right panel labeled IVDR: a labeled human blood specimen tube entering a laboratory analyzer with diagnostic results. Add clear contrasting arrows from patient to monitor and specimen to analyzer. White background, blue-gray clinical vector style, restrained teal accent, crisp linework, no textures or gradients, generous safe margins.","caption":"MDR versus IVDR information pathways","size":"1024x1024"}
B Worked example: specimen-based diagnostics
A manufacturer develops a compact instrument that analyzes capillary blood samples to provide results used in diabetes management. A hypothetical user is a 54-year-old adult with diabetes, hypertension, and osteoarthritis. The product also displays ambient room temperature. The manufacturer argues that portability and the electronic display make the instrument similar to a general patient-monitoring device.
Identify the task: Choose the most appropriate qualification framework.
Extract facts: The claimed clinical information results from in vitro analysis of human-derived blood specimens.
Apply the rule: Evaluate the instrument using the IVDR definition.
Eliminate distractors: Portability, display technology, patient comorbidities, and room-temperature readout do not replace the specimen-based intended purpose.
Verify: Record IVDR qualification and proceed to the separate Annex VIII classification assessment.
C Exam trap
Tempting wrong conclusion: Any diagnostic instrument is an MDR medical device. Why tempting: Diagnosis is explicitly included in the MDR medical-purpose framework. Eliminating clue: The instrument is intended to examine a specimen derived from the human body in vitro for qualifying clinical information.
D Checkpoint MCQ
Question: A manufacturer supplies an analyzer intended specifically to test human specimens and report a biomarker used in clinical decision-making. Which initial framework is most appropriate?
A. MDR because all diagnostic equipment falls within the general medical device definition.
B. IVDR because the specified clinical information derives from in vitro examination of human specimens.
C. MDR Annex XVI because the analyzer is a physical instrument.
D. General laboratory equipment because a licensed laboratory operates it.
Correct answer: B. A is tempting because the instrument supports diagnosis, but it disregards the IVD-specific definition. B correctly identifies the controlling specimen and intended-information characteristics. C is tempting because Annex XVI covers some nonmedical-purpose products, but this product has a clinical diagnostic purpose. D is tempting because laboratory setting matters operationally, but specific diagnostic claims defeat an automatic general-purpose assumption.
If you missed this: Review Distinguish MDR devices, IVDR devices, and adjacent categories - focus on human-derived specimens examined in vitro for qualifying information.
Quick Recall:
Complete: Qualification occurs before ________. Answer: Classification.
True or false: A medical claim automatically places a product under MDR rather than IVDR. Answer: False.
What matters more than the physical location of an analyzer? Answer: Its manufacturer-defined intended purpose.
1.1.1.3 3. Resolve software, accessories, research-only claims, and borderline products
A Explanation and decision conflict
WHY THIS IS TESTED: A seemingly nondevice feature may be part of a regulated function, while a medical-looking product may lack sufficient evidence for qualification. The correct decision depends on the full regulatory and functional context.
Medical device software requires functional analysis. Administrative scheduling, passive storage, and general communication features do not automatically establish medical device status. Software intended to interpret images for diagnosis can raise MDR questions; software intended to evaluate in vitro specimen information can raise IVDR questions. A software module may require independent qualification even when supplied with hardware.
Accessories require a specific enabling relationship to particular regulated devices. Generic compatibility is not, by itself, enough to establish accessory status. For research-use-only products, a manufacturer must examine whether the limited research purpose is consistent across labeling, promotion, functionality, and customer-facing instructions. An RUO label is not a substitute for this assessment.
Products combining medicinal and device elements require particular care. Assess the principal intended action, integration of components, and applicable provisions rather than assuming every combination is regulated identically. The same disciplined reasoning applies to products that overlap with cosmetics or other frameworks.
1. Separate functions
Identify administrative, analytical, therapeutic, and supporting functions.
2. Determine the intended regulated relationship
Assess stand-alone device functionality or accessory support.
3. Compare claims with actual intended use
Check research-only and general-purpose statements for consistency.
4. Evaluate borderline characteristics
Investigate medicinal action, integrated components, and competing frameworks.
5. Escalate unresolved qualification questions
Preserve evidence and seek an appropriate documented regulatory determination.
The relationship among these categories is illustrated in Fig 3.
Fig 3. Borderline qualification screening Exam takeaway: Software labels, accessory claims, and research designations require function-specific evidence rather than automatic exemptions.
flowchart TD
A[Product with uncertain status] --> B{Specific medical or IVD function?}
B -->|Yes| C[Evaluate MDR or IVDR definition]
B -->|No or unclear| D{Specifically enables device functionality?}
D -->|Yes| E[Evaluate accessory definition]
D -->|No| F[Assess research and general-purpose claims]
C --> G[Review competing regulatory frameworks]
E --> G
F --> G
G --> H[Document conclusion and unresolved questions]
Software qualification comparison Exam takeaway: Distinguish administrative data functions from software intended to produce medical or IVD information.
{"prompt":"Original square educational vector diagram with three labeled software cards side by side. Administrative: calendar, storage folder, and message icons. MDR Assessment: patient medical image with a diagnostic analysis indicator. IVDR Assessment: human blood specimen, assay result, and diagnostic interpretation screen. Show distinct arrows to three different regulatory assessment folders, not blanket regulatory outcomes. White background, professional blue-gray palette, small teal highlights, clean thin outlines, readable short labels, wide margins, no gradients or textures.","caption":"Software functionality and qualification pathways","size":"1024x1024"}
Research-use-only claims review Exam takeaway: A research designation must agree with the product's intended use and manufacturer communications.
{"prompt":"Square regulatory compliance illustration showing a research laboratory kit in the center and a four-part consistency review around it. Cards labeled RUO Label, Instructions, Marketing, and Intended Use, with a magnifying glass highlighting potential conflicting diagnostic wording on the marketing card. White background, cool blue and gray vector illustration, restrained amber warning accent, simple precise shapes, generous margins, no decorative elements or gradients.","caption":"Research-use-only claim consistency review","size":"1024x1024"}
B Worked example: research designation with clinical claims
A supplier sells a molecular assay kit labeled for research use only. Its website separately states that the kit identifies a genetic marker to guide individual treatment selection. A hospital laboratory is evaluating the kit for a 46-year-old patient with asthma, hypertension, and a history of migraine. An incidental lipid result appears in the clinical record. The supplier's sales representative describes the kit as a research platform.
Identify the task: Determine whether the research designation is sufficient to exclude the kit from IVDR assessment.
Extract facts: The product examines human-derived specimens, and the manufacturer communicates a potential patient-specific treatment purpose.
Apply the rule: Compare the claimed use against the IVDR definition and assess conflicts among manufacturer statements.
Eliminate distractors: The RUO label, incidental lipid result, and informal sales description do not resolve the conflicting treatment-selection claim.
Verify: Require a documented clarification of intended purpose and perform an IVDR qualification review before endorsing a research-only conclusion.
C Exam trap
Tempting wrong conclusion: The words research use only conclusively remove a product from IVDR consideration. Why tempting: Research products are often differentiated from products intended for clinical diagnosis. Eliminating clue: The manufacturer's separate communication makes a patient-specific treatment-selection claim.
D Checkpoint MCQ
Question: A laboratory assay is labeled RUO but manufacturer promotional material proposes its use to select therapy for individual patients. What is the most appropriate next step?
A. Accept RUO status because product labeling is always the exclusive qualification source.
B. Classify it immediately as a Class D IVD because treatment selection is mentioned.
C. Resolve the conflicting intended-purpose evidence and assess IVDR applicability.
D. Treat it as an MDR accessory because the assay requires laboratory equipment.
Correct answer: C. A is tempting because formal labeling is important, but manufacturer promotions are relevant evidence. B is tempting because treatment decisions can carry substantial clinical risk, but IVDR qualification and classification are distinct determinations. C is correct because the contradiction requires assessment rather than an automatic exemption or class assignment. D is tempting because the kit operates with instruments, but instrument dependence does not establish MDR accessory status.
If you missed this: Review Resolve software, accessories, research-only claims, and borderline products - focus on consistency of research labels with manufacturer clinical claims.
1.1.1.4 4. Recognize MDR Annex XVI products without an intended medical purpose
A Explanation and decision conflict
WHY THIS IS TESTED: The general approach to MDR qualification begins with medical intended purpose, but MDR Annex XVI expressly identifies certain groups of products without such a purpose. Ignoring this separate scope pathway can produce an incorrect exclusion.
MDR Article 1(2) and Annex XVI establish a framework for specified product groups without an intended medical purpose. Illustrative groups include certain contact lenses and other items introduced into or onto the eye, certain products intended for dermal or mucous membrane filling, equipment intended for liposuction or related procedures, and specified high-intensity electromagnetic radiation equipment intended for skin treatment. The exact Annex XVI group wording and any applicable conditions must be verified rather than generalized to all cosmetic products.
Commission Implementing Regulation (EU) 2022/2346 sets relevant common specifications and was amended by Regulation (EU) 2023/1194. Product-specific transitional provisions may affect the practical compliance timeline. Aesthetic intent does not automatically exclude a product from MDR, but not every aesthetic article is within Annex XVI either.
1. Confirm absence of medical purpose
Assess the intended-purpose record rather than assuming cosmetic intent.
2. Compare exact product group
Evaluate whether the product matches an Annex XVI description.
3. Identify applicable specifications
Assess the relevant common specifications and amended provisions.
4. Verify transitional eligibility
Check the product-specific conditions before relying on an extension.
5. Record compliance implications
Document obligations, supporting evidence, and unresolved questions.
See Fig 4 for a visual Annex XVI screening checklist.
Fig 4. Annex XVI nonmedical-purpose screening Exam takeaway: A product can require MDR assessment despite lacking a medical purpose when it falls within an Annex XVI group.
{"prompt":"Square educational regulatory checklist illustration with a central title Annex XVI Screen. On the left show three neutral representative icons: cosmetic contact lens, dermal filler syringe, and aesthetic energy-based skin treatment equipment. On the right show four sequential checklist cards: Intended Purpose, Exact Annex XVI Group, Common Specifications, and Transitional Conditions. Use directional arrows, white background, cool blue-gray minimal vector style, restrained teal accent, clearly legible text, thin outlines, ample margins, no photorealism or gradients.","caption":"Annex XVI applicability screening","size":"1024x1024"}
Medical purpose and Annex XVI comparison Exam takeaway: The absence of a medical claim is not the end of MDR scope screening.
{"prompt":"Side-by-side square regulatory comparison diagram with white background. Left column labeled Medical Purpose shows a clinical treatment device connected to an MDR definition checklist. Right column labeled No Medical Purpose shows a cosmetic contact lens connected to an Annex XVI group and common specifications checklist. Both lead to a central MDR applicability review, with clearly different routes. Professional blue-gray educational vector style, one muted teal accent, thin outlines, no gradients or textures, spacious framing.","caption":"Two different routes to MDR applicability","size":"1024x1024"}
B Worked example: cosmetic contact lens
A manufacturer markets colored contact lenses solely for aesthetic appearance and expressly disclaims any vision-correction purpose. A potential wearer is a 29-year-old adult with seasonal allergies, eczema, and mild myopia. A recent normal blood count appears in the consumer's medical history. The sales team argues that lack of a medical claim means no MDR consideration is necessary.
Identify the task: Determine whether absence of medical purpose ends the scope analysis.
Extract facts: The product is a contact lens intended for aesthetic use without vision correction.
Apply the rule: Screen against the exact MDR Annex XVI contact-lens group and applicable common specifications.
Eliminate distractors: The consumer's conditions and normal blood count do not determine Annex XVI applicability; the absence of corrective claims does not automatically exclude the product.
Verify: Document the Annex XVI assessment and check relevant specifications and transitional conditions before determining the compliance pathway.
C Exam trap
Tempting wrong conclusion: A product without a medical purpose is always outside the MDR. Why tempting: Medical intended purpose is central to the ordinary device definition. Eliminating clue: The product is an aesthetic contact lens within a specifically identified Annex XVI product group.
D Checkpoint MCQ
Question: A company introduces noncorrective cosmetic contact lenses. Which initial regulatory action is most appropriate?
A. Exclude MDR because the manufacturer makes no medical claim.
B. Apply IVDR because the product contacts a human biological surface.
C. Evaluate the exact MDR Annex XVI group and applicable common specifications.
D. Automatically apply the ordinary MDR medical-purpose definition without considering Annex XVI.
Correct answer: C. A is tempting because ordinary device qualification emphasizes medical purpose, but Annex XVI provides a separate route. B is tempting because the product relates to human anatomy, but no in vitro specimen examination is involved. C correctly identifies the specified nonmedical-purpose pathway. D is tempting because both routes fall under MDR, but it omits the special Annex XVI basis and potentially relevant specifications.
If you missed this: Review Recognize MDR Annex XVI products without an intended medical purpose - focus on the separate statutory product-group screen.
Quick Recall:
True or false: All cosmetic products are MDR Annex XVI products. Answer: False.
Which implementing regulation supplies Annex XVI common specifications? Answer: Regulation (EU) 2022/2346, as amended.
What must accompany review of the group definition? Answer: Applicable common specifications and product-specific transitional conditions.
1.1.1.5 5. Produce a defensible applicability memorandum and manage downstream decisions
A Explanation and decision conflict
WHY THIS IS TESTED: Regulatory teams must transform a qualification opinion into a documented, traceable conclusion that can support design control, labeling, conformity assessment, and subsequent changes.
An applicability memorandum should identify the exact product configuration, intended purpose, evidence sources, applicable legal definition, plausible exclusions or special pathways, conclusions, unresolved questions, and decision ownership. It must distinguish qualification from later classification. A single family-level memorandum may be inadequate where members have materially different purposes or technologies.
The memo also creates an interface with later workstreams. A qualifying MDR device proceeds to MDR Annex VIII classification; a qualifying IVDR device proceeds to IVDR Annex VIII. An Annex XVI product requires the appropriate special analysis. Where a product is manufactured and used within a health institution, applicable exemptions require an independent conditions-based review. Where legacy products are involved, eligibility for extended transitions is separate from product qualification and must not be presumed.
Define the device, variants, software version, and intended market.
2. Summarize intended-purpose evidence
Reference controlled documents and relevant manufacturer statements.
3. State applicable legal reasoning
Apply MDR, IVDR, Annex XVI, or other relevant qualification provisions.
4. Record uncertainties
Identify missing claims, product-action evidence, and necessary decisions.
5. Route the outcome
Initiate classification, applicable exemption analysis, or further regulatory assessment.
Fig 5. Qualification memorandum and downstream compliance Exam takeaway: A documented scope conclusion determines which classification and subsequent compliance pathways are relevant.
flowchart TD
A[Product identification and claims] --> B[Regulatory applicability memorandum]
B --> C{Documented qualification outcome}
C -->|MDR device| D[MDR Annex VIII classification]
C -->|IVDR device| E[IVDR Annex VIII classification]
C -->|Annex XVI product| F[Common specifications assessment]
C -->|Unresolved| G[Further documented assessment]
D --> H[Applicable conformity and lifecycle planning]
E --> H
F --> H
G --> B
Regulatory applicability memorandum template Exam takeaway: A useful memorandum records evidence, reasoning, conclusion, and unresolved qualification questions.
{"prompt":"Square professional educational vector illustration of a regulatory applicability memorandum document on a white desk-free background. Show six readable section bands: Product and Version, Intended Purpose Evidence, Applicable Definitions, Exclusions and Special Routes, Qualification Conclusion, and Open Questions. Include a small document-control icon and connecting lines to MDR, IVDR, Annex XVI, and Further Assessment labels. White background, clean cool-blue and gray palette with muted teal accent, crisp outlines, no gradients or textures, clear margins.","caption":"Structured product qualification memorandum","size":"1024x1024"}
Table 3. Minimum practical contents of an applicability memorandum
How does the product generate its intended effect or information?
Technical description and functional requirements
Statutory qualification
Which definitions fit the facts?
MDR or IVDR Article 2 rationale
Special pathways
Are exclusions, accessories, combination provisions, or Annex XVI relevant?
Documented statutory screen
Conclusion and next steps
What is established, uncertain, and assigned for follow-up?
Decision record and action owners
B Worked example: product family with different intended purposes
A manufacturer sells a general laboratory data viewer, a clinical image-analysis module, and software that interprets results from human-derived blood specimens. An internal demonstration uses records from a 61-year-old person with diabetes, chronic kidney disease, and hypertension. A serum sodium result appears in the demonstration but does not change the three products' intended functions. The commercial team proposes one family-wide MDR classification because all three share a user interface.
Identify the task: Determine whether one qualification decision can cover all modules.
Extract facts: Administrative viewing, medical image analysis, and IVD specimen-result interpretation are distinct intended functions.
Apply the rule: Qualify each module or inseparable product configuration based on its own documented purpose and relevant definitions.
Eliminate distractors: Shared branding, patient details, incidental laboratory findings, and a common interface do not establish identical regulatory status.
Verify: Record a product-specific rationale, investigate the administrative viewer's claims, assess the image module under MDR and the specimen-data module under IVDR, and route each qualifying product to its corresponding classification assessment.
C Exam trap
Tempting wrong conclusion: One shared platform means one uniform regulatory qualification for every module. Why tempting: Common architecture, branding, and quality documentation simplify operational management. Eliminating clue: The modules have materially different manufacturer-defined intended functions.
D Checkpoint MCQ
Question: Which deliverable best completes a product qualification review before classification begins?
A. A final risk-class declaration without supporting intended-purpose documentation.
B. A single conclusion based only on the company's preferred product description.
C. A complete conformity assessment application before deciding which regulation applies.
D. A controlled memorandum identifying evidence, definitions, exclusions, conclusion, and remaining questions.
Correct answer: D. A is tempting because classification is a visible regulatory milestone, but it does not substitute for qualification reasoning. B is tempting because product owners define commercial purpose, but unsupported claims are insufficient. C is tempting because notified body planning is important, but framework selection precedes the appropriate route. D is correct because it creates an auditable and reusable scope decision.
If you missed this: Review Produce a defensible applicability memorandum and manage downstream decisions - focus on recording a traceable scope decision before classification.
TRAPS
Exam Traps & Differentiators
The principal error is substituting a superficial product label for a statutory qualification analysis. The following distinctions support practical regulatory reviews.
Table 4. Similar-looking regulatory categories with different deciding clues
Looks similar
But differs because
Decision clue
MDR diagnostic device versus IVDR diagnostic device
IVDR centers on qualifying in vitro examination of human-derived specimens
Specimen examination and information purpose
Medical device software versus administrative software
Medical-purpose functionality must be established
Intended clinical output
Specific IVD analyzer versus general laboratory instrument
Principal pharmacological action - investigate medicinal product and applicable combination provisions.
One platform, multiple distinct clinical outputs - assess product functions and configurations separately.
Common traps & distractors:
Temptation: Qualify by hospital use. Eliminating clue: The documented function is administrative only.
Temptation: Qualify every diagnostic product under MDR. Eliminating clue: The result comes from qualifying in vitro human-specimen examination.
Temptation: Treat an RUO label as conclusive. Eliminating clue: Manufacturer marketing makes an individual-patient treatment claim.
Temptation: Exclude all aesthetic products. Eliminating clue: An exact Annex XVI product group is potentially applicable.
Temptation: Apply an extended transition automatically. Eliminating clue: The product's statutory transition eligibility has not been established.
Review connection: Return to Establish intended purpose before selecting a regulation whenever two regulatory interpretations initially appear equally plausible. Resolve the factual intended-purpose question before advancing to classification or transition planning.
ALGO
Algorithm / Approach
Use this six-step qualification sequence when reviewing a new product, modified claim, or new product configuration.
Step 1 - Define the product
Record configuration, software, users, functions, and the intended EU commercialization context.
Test qualifying medical purpose, human-derived specimen examination, principal action, and potential accessory status.
Step 4 - Screen special categories
Evaluate medicinal or combination products, research-only claims, general laboratory use, and MDR Annex XVI.
Step 5 - Resolve or document uncertainty
Identify missing facts, conflicting representations, and appropriate further assessment.
Step 6 - Authorize the next compliance workstream
Complete the applicability memorandum, then initiate classification, special-pathway assessment, or other appropriate follow-up.
What comes next: For products that qualify under MDR or IVDR, the regulatory team must assess risk classification, applicable conformity assessment, quality and risk management, and supporting technical documentation. For possible health-institution products or legacy products, separate statutory eligibility determinations are required. As of 1 November 2026, manufacturers should distinguish applicable extended transition arrangements from ordinary product qualification; dates and conditions cannot be assumed from a product's legacy status alone.
QUIZ
Self-check quiz
Choose the most appropriate answer for each situation before consulting the explanations.
Question 1 - Foundational
A manufacturer's software only stores and retrieves medical images. No clinical interpretation, prediction, or diagnostic output is claimed. Which conclusion is best supported?
A. It is automatically an MDR medical device because the stored images are medical.
B. It is automatically an IVDR because the image files contain patient information.
C. Its documented purpose does not, on these facts alone, establish medical device status; confirm the complete claims.
D. It qualifies as an MDR Annex XVI product because no clinical analysis is performed.
Question 2 - Application
A manufacturer offers software intended to interpret results generated by in vitro examination of human blood specimens and provide information about a patient's treatment response. Which framework should be investigated first?
A. IVDR, because the intended diagnostic information derives from in vitro human-specimen examination.
B. MDR, because all stand-alone software is assessed under MDR.
C. MDR Annex XVI, because the product does not directly contact a patient.
D. General laboratory equipment provisions, because the software has no physical sampling component.
Question 3 - Application
A manufacturer promotes a research-labeled assay for patient-specific diagnosis. What is the most appropriate qualification action?
A. Accept the RUO label without further review.
B. Immediately assume the assay is a low-risk IVDR product.
C. Assess the assay as an MDR accessory because it relies on an analyzer.
D. Investigate the inconsistent manufacturer claims and determine IVDR applicability from the documented intended purpose.
Question 4 - Analysis
A manufacturer markets noncorrective cosmetic contact lenses without a medical purpose. What is the most defensible initial regulatory decision?
A. Exclude MDR because a medical indication is absent.
B. Screen the product against MDR Annex XVI and the applicable common specifications.
C. Assess IVDR because the product comes into contact with human tissue.
D. Classify the product as an ordinary MDR medical device before determining its scope basis.
Question 5 - Integration
A shared software platform contains an administrative data viewer, an image-analysis function intended for diagnosis, and an IVD result-interpretation module. What should regulatory affairs do first?
A. Assign one MDR classification to the full platform because its architecture is shared.
B. Treat all modules as accessories to the same computing hardware.
C. Document the distinct intended purposes and assess the applicable framework for each relevant module or configuration.
D. Select the IVDR framework for the entire platform because one module uses IVD data.
ANSWERS
Answer key & explanations
1.1.1.6 Question 1 - C
A: Tempting because images originate in clinical care; incorrect because passive handling of medical data does not by itself establish a qualifying medical purpose.
B: Tempting because patient information is involved; incorrect because IVDR requires the relevant in vitro specimen-related purpose.
C: Correct because intended clinical functionality has not been demonstrated and complete manufacturer claims must still be confirmed.
D: Tempting because Annex XVI addresses nonmedical-purpose products; incorrect because there is no basis to identify the software as an Annex XVI group.
If you missed this: Review Establish intended purpose before selecting a regulation - focus on distinguishing administrative functionality from a qualifying medical intended purpose.
1.1.1.7 Question 2 - A
A: Correct because the intended interpretation concerns information derived from qualifying in vitro examination of human specimens.
B: Tempting because stand-alone medical software can fall under MDR; incorrect because software can also qualify as an IVD.
C: Tempting because there is no direct physical contact; incorrect because Annex XVI concerns specified product groups rather than all noncontact software.
D: Tempting because software lacks sampling hardware; incorrect because a software system may independently fulfill a qualifying IVD purpose.
If you missed this: Review Distinguish MDR devices, IVDR devices, and adjacent categories - focus on the intended specimen-related information.
1.1.1.8 Question 3 - D
A: Tempting because formal research labeling matters; incorrect because conflicting manufacturer clinical claims require investigation.
B: Tempting because classification feels like a decisive answer; incorrect because qualification must precede risk classification.
C: Tempting because the assay operates with equipment; incorrect because equipment dependence does not establish MDR accessory status.
D: Correct because a claimed patient-specific diagnostic use requires a documented assessment of the product's intended purpose and IVDR scope.
If you missed this: Review Resolve software, accessories, research-only claims, and borderline products - focus on manufacturer claims that conflict with RUO labeling.
1.1.1.9 Question 4 - B
A: Tempting because ordinary devices have an intended medical purpose; incorrect because Annex XVI creates a separate pathway for specified groups.
B: Correct because the specified product category warrants review under Annex XVI and relevant common specifications.
C: Tempting because the product interacts with the human body; incorrect because IVDR relates to qualifying in vitro specimen examination.
D: Tempting because the product may ultimately be regulated under MDR; incorrect because its special scope basis must be established first.
If you missed this: Review Recognize MDR Annex XVI products without an intended medical purpose - focus on exact product-group coverage before selecting the downstream pathway.
1.1.1.10 Question 5 - C
A: Tempting because shared architecture suggests one device family; incorrect because different intended functions can require distinct qualification assessments.
B: Tempting because the modules depend on a common platform; incorrect because technical dependency alone does not establish accessory qualification.
C: Correct because each relevant function or configuration must be assessed against its applicable statutory definition and intended purpose.
D: Tempting because one module has an IVD function; incorrect because that function cannot automatically determine the regulatory status of unrelated modules.
If you missed this: Review Produce a defensible applicability memorandum and manage downstream decisions - focus on product-specific intended-purpose documentation and separate qualification conclusions.
RAPID
Rapid review / cheat-sheet
Scope versus class - qualification identifies the legal framework; classification follows.
Clinical setting - hospital use does not independently establish device status.
Diagnostic information - identify whether it derives from qualifying in vitro human-specimen examination.
Software status - independent medical or IVD functionality matters more than the hardware platform.
Accessories - require a qualifying manufacturer-intended relationship to specific device functionality.
RUO designation - assess consistency across the manufacturer's evidence.
Medicinal borderline - examine principal intended action and relevant combination provisions.
Annex XVI - specified nonmedical-purpose groups may remain subject to MDR obligations.
Common specifications - verify the applicable amended framework and product-specific provisions.
Product families - shared branding does not establish shared qualification.
Next workstream - route qualified products to classification and applicable compliance planning without assuming transition eligibility.
See also: MDR and IVDR Health-Institution Exemption Eligibility; Economic Operator and PRRC Responsibilities; MDR Annex VIII Classification; IVDR Annex VIII Classification; Classification Rationale and Assessment Pathways.
End of your free lesson
Keep going with the full EU MDR and IVDR Compliance Certificate Program
You just studied the way members do, in the same lesson interface. Full access unlocks every lesson, the question bank and flashcards for a full year.